Evaluation of Prognostic Factors for Unresectable or Recurrent Gastric Cancer Treated with Nivolumab

被引：0
|
作者：
Kenji Ishido
Satoshi Tanabe
Chikatoshi Katada
Yu Ishibashi
Gen Kitahara
Mie Onoue
Yo Kubota
Yasuaki Furue
Takuya Wada
Akinori Watanabe
Chika Kusano
机构：
[1] Kitasato University School of Medicine,Department of Gastroenterology
[2] Kitasato University School of Medicine,Research and Development Center for New Medical Frontiers
来源：
Journal of Gastrointestinal Cancer | 2023年 / 54卷
关键词：
Gastric cancer; Nivolumab; Neutrophil-to-lymphocyte ratio; Immune-related adverse events;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：485 / 491
页数：6
相关论文
共 50 条
  • [21] Alterations in Intratumoral Immune Response before and during Early-On Nivolumab Treatment for Unresectable Advanced or Recurrent Gastric Cancer
    Sato, Yasuyoshi
    Yamashita, Hiroharu
    Kobayashi, Yukari
    Nagaoka, Koji
    Hisayoshi, Tetsuro
    Kawahara, Takuya
    Kuroda, Akihiro
    Saito, Noriyuki
    Iwata, Ryohei
    Okumura, Yasuhiro
    Yagi, Koichi
    Aiko, Susumu
    Nomura, Sachiyo
    Kakimi, Kazuhiro
    Seto, Yasuyuki
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (23)
  • [22] Neutrophil-to-lymphocyte ratio and C-reactive protein–to–albumin ratio as prognostic factors for unresectable advanced or recurrent gastric cancer
    Tsutomu Namikawa
    Shigeto Shimizu
    Keiichiro Yokota
    Nobuhisa Tanioka
    Masaya Munekage
    Sunao Uemura
    Hiromichi Maeda
    Hiroyuki Kitagawa
    Michiya Kobayashi
    Kazuhiro Hanazaki
    Langenbeck's Archives of Surgery, 2022, 407 : 609 - 621
  • [23] THERAPEUTIC OUTCOMES AND PROGNOSTIC FACTORS IN UNRESECTABLE GALLBLADDER CANCER TREATED WITH GEMCITABINE PLUS CISPLATIN
    You, Min Su
    Ryu, Ji Kon
    Choi, Young Hoon
    Shin, Bang-sup
    Paik, Woo Hyun
    Lee, Sang Hyub
    Kim, Yong-Tae
    GASTROENTEROLOGY, 2018, 154 (06) : S953 - S953
  • [24] Prognostic Factors of Unresectable Pancreatic Cancer Treated with Nafamostat Mesilate Combined with Gemcitabine Chemotherapy
    Furukawa, Kenei
    Uwagawa, Tadashi
    Iwase, Ryota
    Haruki, Koichiro
    Fujiwara, Yuki
    Gocho, Takeshi
    Shiba, Hiroaki
    Misawa, Takeyuki
    Yanaga, Katsuhiko
    ANTICANCER RESEARCH, 2012, 32 (11) : 5121 - 5126
  • [25] Therapeutic outcomes and prognostic factors in unresectable gallbladder cancer treated with gemcitabine plus cisplatin
    Min su You
    Ji Kon Ryu
    Young Hoon Choi
    Jin Ho Choi
    Gunn Huh
    Woo Hyun Paik
    Sang Hyub Lee
    Yong-Tae Kim
    BMC Cancer, 19
  • [26] Therapeutic outcomes and prognostic factors in unresectable gallbladder cancer treated with gemcitabine plus cisplatin
    You, Min Su
    Ryu, Ji Kon
    Choi, Young Hoon
    Choi, Jin Ho
    Huh, Gunn
    Paik, Woo Hyun
    Lee, Sang Hyub
    Kim, Yong-Tae
    BMC CANCER, 2019, 19 (1)
  • [27] Phase I study of nivolumab or nivolumab/cisplatin/gemcitabine to treat unresectable/recurrent biliary tract cancer
    Morizane, Chigusa
    Ikeda, Masafumi
    Ueno, Makoto
    Kobayashi, Satoshi
    Ohno, Izumi
    Kondo, Shunsuke
    Okano, Naohiro
    Kimura, Keisuke
    Asada, Suguru
    Namba, Yoshinobu
    Okusaka, Takuji
    Furuse, Junji
    ANNALS OF ONCOLOGY, 2019, 30
  • [28] PROGNOSTIC FACTORS IN LOCALLY RECURRENT RECTAL-CANCER TREATED BY RADIOTHERAPY
    JAMES, RD
    EDDLESTON, B
    JOHNSON, R
    ZHENG, G
    BRITISH JOURNAL OF CANCER, 1983, 47 (04) : 557 - 558
  • [29] Prognostic factors in patients with recurrent ovarian cancer treated with radiation therapy
    Kosaka, Nobuaki
    Hasegawa, Kiyoshi
    Kiuchi, Kaori
    Motegi, Emi
    Ejima, Yasuo
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2021, 42 (02) : 311 - 318
  • [30] Prognostic factors in patients with recurrent head and neck cancer treated with reirradiation
    Krstevska, V.
    Tolevska, C.
    Zafirova-Ivanova, B.
    Stojkovski, I.
    Crvenkova, S.
    JOURNAL OF BUON, 2008, 13 (03): : 369 - 376
12345